Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,545.5
-13.6 (-0.53%)

 

  • STI Straits Times Index
    2,545.5
    -13.6 (-0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.7
    -6.5 (-0.41%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,377.4
    -154.2 (-0.63%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,379.3
    25.2 (0.75%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,329.9
    -88.2 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,157.8
    13.9 (0.27%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,268.2M
  • Value: 1,358.9M
  • Rise: 113
  • Fall: 217
  • Unch: 478

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008+0.001
ThaiBev0.605-0.020
Genting Sing0.680-0.030
Asian Healthcare0.285+0.050
Vicplas Intl0.390+0.065
ISDN0.395+0.030
AsiaMedic0.023+0.002
CNMC Goldmine0.360+0.015
Rex Intl0.184-0.003
Medtecs Intl0.970-0.030

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

INDIA GLOBALIZATION CAPITAL INC INDIA GLOBALIZATION CAPITAL
Updated on 07 Aug 2020 (End of trading day)
Last (USD): 0.705 Change: +0.001 High: 0.710 Remarks: -
Change (%): +0.18 Low: 0.680
Open 0.710 Yesterday's Close 0.7037
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 416,924 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.23927 Trailing EPS (USD) e -0.23927 NAV (USD) b 0.8680
PE a - Trailing PE f - Price / NAV b 0.8122
Dividend (USD) d - Cash In Hand (USD) g 0.2374 Issued & Paid-up Shares c 41,186,100
Dividend Yield (%) d - Price / Cash In Hand g 2.970 Treasury Shares h -
Market Cap (M) 21.553 Enterprise Value (M) 9.749
Piotroski F Score 1 Exchange Code IGC Par Value ( $ ) n.a.
52 Weeks Volatility (%) 88.29 Free Float (%) 83.0
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference INDIA GLOBALIZATION CAPITAL INC NYSE American 21.553 - - 0.8122 -
Industry Biotechnology NYSE American 131.548 - - 4.1263 -
Local Peer NANOVIRICIDES INC NYSE American 399.876 - - 27.9295 -
Local Peer IBIO INC NYSE American 352.712 - - 88.9930 -
Local Peer CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL NYSE American 298.239 - - 58.9041 -
Local Peer PFENEX INC NYSE American 195.526 184.790 - 2.6461 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 136.183 - - 1.3695 -
Local Peer CEL-SCI CORP NYSE American 113.806 - - 9.3217 -
Local Peer AIM IMMUNOTECH INC NYSE American 97.546 - - 2.8403 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 85.569 2.392 2.307 0.9871 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 81.763 - - 1.1103 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 75.281 - - -4.6736 -
Local Peer 22ND CENTURY GROUP INC NYSE American 74.963 - - 1.3916 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 68.053 - - 2.0325 -
Other Local Peers ORAGENICS INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American)
Global Peer AMGEN INC NASDAQ 140,970.689 17.976 19.314 13.2255 2.433
Global Peer CSL ASX 126,915.776 47.305 43.813 14.6750 0.949
Global Peer GILEAD SCIENCES INC NASDAQ 86,945.482 16.143 - 4.8231 3.669
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer VERTEX PHARMACEUTICAL NASDAQ 71,104.886 60.422 34.172 9.4564 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 65,985.364 31.187 22.117 7.2852 -
Global Peer ILLUMINA INC NASDAQ 52,282.020 52.178 75.443 11.4578 -
Global Peer BIOGEN INC NASDAQ 48,397.867 8.219 8.166 4.2797 -
Global Peer WUXI BIO HKEx 223,626.656 194.531 194.531 15.6376 -
Global Peer MODERNA INC NASDAQ 28,811.858 - - 9.7770 -
Other Global Peers SEATTLE GENETICS INC (NASDAQ), SINO BIOPHARM (HKEx), ALEXION PHARMACEUTICAL INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), NOVAVAX INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), EXELIXIS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), Lonza (SGX), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), GENSCRIPT BIO (HKEx), FIBROGEN INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), 3SBIO (HKEx), AGIOS PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), FATE THERAPEUTICS (NASDAQ), HAOHAI BIOTEC (HKEx), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), TG THERAPEUTICS INC (NASDAQ), VIVA BIOTECH (HKEx), BENITEC BIOPHARMA INC (NASDAQ), ALLOVIR INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIELA BIO INC (NASDAQ), ALPHAMAB-B (HKEx), LIGAND PHARMACEUTICAL INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), XENCOR INC (NASDAQ), UNIQURE N.V. (NASDAQ), VERACYTE INC (NASDAQ), MESOBLAST LTD (ASX), VAXCYTE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), MACROGENICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), COHERUS BIOSCIENCES INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), EPIZYME INC (NASDAQ), CORTEXYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), ARVINAS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ASCENTAGE-B (HKEx), ESPERION THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), VAXART INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), RETROPHIN INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), PRECIGEN INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), NKARTA INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), PASSAGE BIO INC (NASDAQ), OMEROS CORP (NASDAQ), KINTOR PHARMA-B (HKEx), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KADMON HLDGS INC (NYSE), FREQUENCY THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PERSONALIS INC (NASDAQ), AKOUOS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), AGENUS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), AVROBIO INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), GERON CORP (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), ARDELYX INC (NASDAQ), ATHERSYS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), ANAPTYSBIO INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), DPHARMA (Bursa), LEE'S PHARM (HKEx), SINOVAC BIOTECH LTD (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), ASPIRA WOMENS HEALTH INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), IVERIC BIO INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), MERUS B V (NASDAQ), ESSEX BIO-TECH (HKEx), MAGENTA THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), MEDICINOVA INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), NEXTCURE INC (NASDAQ), CHIASMA INC (NASDAQ), TREVENA INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), TELIX PHARMACEUTIC (ASX), DYADIC INTERNATIONAL INC (NASDAQ), VERASTEM INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), XOMA CORP (NASDAQ), IMUGENE LIMITED (ASX), VTV THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), EQUILLIUM INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), NEXT SCIENCE LTD (ASX), JOUNCE THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), INMUNE BIO INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), INFLARX N V (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), LUMOS PHARMA INC (NASDAQ), ORGENESIS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ENZO BIOCHEM INC (NYSE), ELOXX PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), NEUROBO PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), RECRO PHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), UNI-BIO GROUP (HKEx), LA JOLLA PHARMACEUTICAL CO (NASDAQ), ARAVIVE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), RESTORBIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), COHBAR INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ANTEOTECH LIMITED (ASX), MEMPHASYS LTD (ASX), AXOVANT GENE THERAPIES LTD (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SOLIGENIX INC (NASDAQ), IMMUTEP LTD (ASX), VISTAGEN THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), INFINITY PHARMACEUTICALS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), GENETIC TECHNOLOGIES (ASX), BIOTRON (ASX), SUNESIS PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PRECIPIO INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CT ENTERPRISE (HKEx), PULMATRIX INCORPORATED (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BIONOMICS LTD (ASX), ADVAXIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), BIOCARDIA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), EVOGENE LTD (NASDAQ), BIOSINO BIO-TEC (HKEx), AETERNA ZENTARIS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), CONSTELLATION TECHNOLOGIES LTD (ASX), CYCLACEL PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), Suntar Eco-City (SGX), ITERUM THERAPEUTICS PLC (NASDAQ), REGENEUS LTD (ASX), REGENT PACIFIC (HKEx), ACTINOGEN MEDICAL LTD (ASX), BIO-PATH HOLDINGS INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), RHINOMED LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), PLUS THERAPEUTICS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), SENESTECH INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), CRYOSITE (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), HAO WEN H-NEW (HKEx), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), HAO WEN H-OLD (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.025
-3.42 %
10 Days -+0.035
+5.22 %
20 Days -+0.150
+27.03 %
Medium Term Return 3 Months -+0.201
+39.88 %
6 Months -+0.085
+13.71 %
1 Year --0.375
-34.72 %
Long Term Return 2 Years -+0.335
+90.54 %
3 Years -+0.325
+85.53 %
5 Years -+0.437
+163.06 %
Annualised Return Annualised --
+21.34 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.263 - 1.310 Change From 1 Year Low +0.442 % Change From 1 Year Low (%) +168.06
Change From 1 Year High -0.605 % Change From 1 Year High (%) -46.18
2 Years Range 0.263 - 14.580 Change From 2 Years Low +0.442 % Change From 2 Years Low (%) +168.06
Change From 2 Years High -13.875 % Change From 2 Years High (%) -95.16
5 Years Range 0.135 - 14.580 Change From 5 Years Low +0.570 % Change From 5 Years Low (%) +422.22
Change From 5 Years High -13.875 % Change From 5 Years High (%) -95.16
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications such as Alzheimer's disease, Parkinson's disease, and pain. It operates through the Infrastructure Business and Life Sciences segments. The Infrastructure Business segment involves the rental of heavy construction equipment, execution of construction contracts, and purchase and reseal of physical commodities used in infrastructure. The Life Sciences segment includes a biotech component, and a vertically integrated hemp-cannabinoid based healthcare and wellness business, which involves the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.

Historical Price Data

Date Open High Low Close Volume VWAP
07 Aug 2020 0.710 0.710 0.680 0.705 416,924 -
06 Aug 2020 0.670 0.708 0.650 0.704 1,494,796 -
05 Aug 2020 0.650 0.710 0.642 0.680 1,273,707 -
04 Aug 2020 0.695 0.695 0.632 0.658 1,277,286 -
03 Aug 2020 0.613 0.768 0.583 0.730 2,887,047 -
31 Jul 2020 0.590 0.640 0.590 0.610 1,117,346 -
30 Jul 2020 0.629 0.629 0.582 0.620 785,134 -
29 Jul 2020 0.650 0.660 0.599 0.605 1,734,095 -
28 Jul 2020 0.770 0.830 0.653 0.700 8,991,276 -
27 Jul 2020 0.550 0.697 0.550 0.670 9,485,025 -
24 Jul 2020 0.550 0.570 0.546 0.552 154,738 -
23 Jul 2020 0.552 0.572 0.541 0.560 353,469 -
22 Jul 2020 0.571 0.581 0.542 0.563 439,481 -
21 Jul 2020 0.600 0.600 0.565 0.581 791,826 -
20 Jul 2020 0.575 0.575 0.553 0.565 455,211 -
17 Jul 2020 0.570 0.570 0.540 0.543 366,323 -
16 Jul 2020 0.541 0.564 0.530 0.564 459,951 -
15 Jul 2020 0.540 0.550 0.520 0.526 400,363 -
14 Jul 2020 0.530 0.552 0.520 0.539 395,152 -
13 Jul 2020 0.570 0.570 0.551 0.555 399,574 -
10 Jul 2020 0.577 0.590 0.560 0.577 351,194 -
09 Jul 2020 0.556 0.579 0.556 0.567 245,063 -
Summary
Current 2 Weeks
(27 Jul 2020 to 07 Aug 2020)
0.550 0.830 0.550 0.705 29,462,636 -
Previous 2 Weeks
(13 Jul 2020 to 24 Jul 2020)
0.570 0.830 0.550 0.552 4,216,088 -
4 Weeks from
(12 Jun 2020 to 10 Jul 2020)
0.600 0.830 0.550 0.577 19,207,637 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.